| |||||||||
Type Mutant Strain; Transgenic; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation F?+2p Description
C57BL/6-TgN(Amy1TAg)501Knw mice are viable and fertile. They express the SV40 tumor antigen under control of the liver promoter of the mouse alpha-amylase gene (Amy1a). This transgenic strain develops metastatic osteosarcomas at about 13 months of age. Note: This line, '501', contains the same trangene constuct as line '354' (Stock No. 003445). Divergent tumor development between these lines is reported to be a result of different transgene integration sites.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Amy1
000628 B6.CE-A Amy1b Amy2b/J 003445 C57BL/6J-Tg(Amy1TAg)354Knw/J 000187 LT.CAST-Amy1b/J View Strains carrying other alleles of Amy1 (3 strains)
Strains carrying other alleles of TAg
008215 (C57BL/6-Tg(TRAMP)8247Ng/J X FVB/NJ)F1/J 003382 B10.D2-Tg(C3-1-TAg)cJeg/J 008247 B6.Cg-Tg(Ela1-TAg*)289Mjt/J 003380 B6.FVB-Tg(C3-1-TAg)cJeg/J 003135 C57BL/6-Tg(TRAMP)8247Ng/J 003445 C57BL/6J-Tg(Amy1TAg)354Knw/J 003477 C57BL/6J-Tg(SV)419Bri/J 003476 C57BL/6J-Tg(SV)427Bri/J 002233 C57BL/6J-Tg(SV)7Bri/J 003189 C57BL/6J-Tg(WAPTAg)3Knw/J 003188 C57BL/6J-Tg(WapTAg)1Knw 005564 FVB(Cg)-Tg(Ins2-CALM1)26Ove Tg(Cryaa-TAg)1Ove/PneJ 003381 FVB-Tg(C3-1-TAg)cJeg/J 002380 NOD.Cg-Tg(Ins2-TAg)1Lt Prkdcscid/DvsJ 002033 NOD/ShiLt-Tg(RipTAg)1Lt/J View Strains carrying other alleles of TAg (15 strains)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(Amy1TAg)501Knw/0
involves: C57BL/6
- immune system phenotype
- abnormal CD8-positive T cell physiology (MGI Ref ID J:84288)
- T cells from transgenic mice exposed to T antigen respond inefficiently to subsequent immunization with T antigen in T cell transfer experiments
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
TAg relatedCancer Research
Increased Tumor Incidence (Other Tissues/Organs: osteosarcoma)
Other (tumor metastasis)
Apoptosis Research
Extracellular Modulators
| Allele Symbol | Tg(Amy1TAg)501Knw | ||
|---|---|---|---|
| Allele Name | transgene insertion 501, Barbara Knowles | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | p600T; | ||
| Strain of Origin | C57BL/6J | ||
| Expressed Gene | TAg, SV40 large T-antigen, SV40 | ||
| Simian virus 40 T antigen (SV40Tag) is a multifunctional regulatory protein that stimulates gene transcription and forms complexes with cell cycle-regulatory proteins such as Trp53 and Rb1 that are implicated in human breast cancer. | |||
| Promoter | Amy1, amylase 1, salivary, mouse, laboratory | ||
| General Note |
Line 354 was also produced. Transgenic mice on a C57BL/6J background are viable and fertile. They develop metastatic osteosarcomas at about 13 months of age. The difference in tumor development between these mice and transgenic mice carrying line 354is reported to be a result of different transgene integration sites. | ||
| Molecular Note | The transgene encodes an alpha-amylase-SV40 T-antigen hybrid protein under control of the liver promoter of the mouse alpha-amylase 1, salivary, gene. [MGI Ref ID J:90326] | ||
Genotyping Protocols
TAg, SV, STD PCR, vers. 2
Helpful Links
Optimizing PCR Protocols
Fox N; Crooke R; Hwang LH; Schibler U; Knowles BB; Solter D. 1989. Metastatic hibernomas in transgenic mice expressing an alpha-amylase-SV40 T antigen hybrid gene. Science 244(4903):460-3. [PubMed: 2785714] [MGI Ref ID J:90326]
Knowles BB; McCarrick J; Fox N; Solter D; Damjanov I. 1990. Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene. Am J Pathol 137(2):259-62. [PubMed: 2386195] [MGI Ref ID J:90730]
Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB. 2000. Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas Transgenic Res 9(2):115-25. [PubMed: 10951695] [MGI Ref ID J:63776]
Tg(Amy1TAg)501Knw relatedKnowles BB; McCarrick J; Fox N; Solter D; Damjanov I. 1990. Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene. Am J Pathol 137(2):259-62. [PubMed: 2386195] [MGI Ref ID J:90730]
Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB. 2000. Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas Transgenic Res 9(2):115-25. [PubMed: 10951695] [MGI Ref ID J:63776]
Schell TD; Knowles BB; Tevethia SS. 2000. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas. Cancer Res 60(11):3002-12. [PubMed: 10850449] [MGI Ref ID J:62541]
Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS. 2003. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. J Immunol 171(2):697-707. [PubMed: 12847236] [MGI Ref ID J:84288]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.